In 14 out of 34 cancer types analyzed, CD40LG exhibited significant down-regulation in tumor specimens, including KICH, ACC, UCEC, SKCM, LUAD, READ, BLCA, LUSC, WT, THCA, READ, UCS, ALL, and HNSC (Figure 1A). This evidence concerns the gene BCR and neoplasm.